Beta
Company data is growing.
← All companies
/
Top lists
/
Procter & Gamble
Procter & Gamble
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
65 299
65 058
66 832
67 684
70 950
76 118
80 187
82 006
84 039
84 284
Operating profit (EBIT)
13 441
13 955
13 711
5 487
15 706
17 986
17 813
18 134
18 545
20 451
Net income attributable to shareholders
10 508
15 326
9 750
3 897
13 027
14 306
14 742
14 653
14 879
15 974
EBIT margin
20,6%
21,5%
20,5%
8,1%
22,1%
23,6%
22,2%
22,1%
22,1%
24,3%
Gross margin
49,6%
50,0%
48,7%
48,6%
50,3%
51,3%
47,4%
47,9%
51,4%
51,2%
Operating cash flow
15 435
12 753
14 867
15 242
17 403
18 371
16 723
16 848
19 846
17 817
Free cash flow
12 121
9 369
11 150
11 895
14 330
15 584
13 567
13 786
16 524
14 044
Cash
7 102
5 569
2 569
4 239
—
—
—
—
—
—
Interest-bearing debt
—
—
—
30 092
—
—
—
—
—
—
0
20 000
40 000
60 000
80 000
100 000
0,0%
10,0%
20,0%
30,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
65 299
65 058
66 832
67 684
70 950
76 118
80 187
82 006
84 039
84 284
13 441
13 955
13 711
5 487
15 706
17 986
17 813
18 134
18 545
20 451